North America Respiratory Care Devices Market Outlook 2025-2035
The North America respiratory care devices market encompasses advanced medical devices for diagnosing, monitoring, and treating respiratory diseases such as COPD, asthma, and obstructive sleep apnea. These devices include ventilators, nebulizers, CPAP machines, pulse oximeters, and consumables that play a pivotal role in hospital and homecare settings. Increased respiratory disorder prevalence, technological innovation, and the growing adoption of home-based healthcare solutions are reshaping market dynamics. The region's aging population, rising air pollution, and recent infectious disease outbreaks fuel demand. By 2025, North America will maintain market leadership through robust investments in product development, regulatory approvals, and strategic initiatives from key players, ensuring resilience and sustained growth through 2035.
Latest Market Dynamics
Key Drivers
Rising prevalence of respiratory disorders: High rates of COPD, asthma, and sleep apnea are driving demand for advanced respiratory care devices, especially post-COVID-19. In June 2024,
introduced expanded home respiratory solutions, targeting the elderly and chronic disease patients.
Technological advancements: Continuous innovation in monitoring, smart inhalers, and portable devices makes respiratory care more accessible and effective. In July 2024, Medtronic launched a new remote patient monitoring solution with AI-driven alerts for respiratory distress.
Key Trends
Shift towards home healthcare: Patients and providers are embracing at-home monitoring and therapy devices for greater comfort and cost savings. In July 2024, ResMed reported surging adoption rates of its portable CPAP and oxygen therapy devices.
Integration of digital health: Devices with wireless connectivity enable real-time data sharing and remote diagnostics, improving outcomes. In June 2024, Masimo integrated cloud-based health analytics into its pulse oximetry platforms.
Key Opportunities
Expansion in telehealth and remote management: Growing acceptance of virtual respiratory assessments is opening new business models. GE Healthcare announced a collaboration in August 2024 to enhance tele-respiratory care for rural areas.
Development of novel filtration technologies: As air pollution worsens, demand for devices featuring HEPA, UV, and electrostatic filtration is rising. In June 2024, Drägerwerk AG & Co. KGaA unveiled its next-gen filtration system for critical care.
Key Challenges
Regulatory complexities: Stringent approval pathways can delay device launches and innovation. Philips Healthcare faces ongoing FDA reviews for its new ventilator series as of July 2024.
High cost of advanced devices: Affordability and reimbursement issues hinder adoption, particularly among small hospitals and homecare users. Teleflex is addressing price sensitivity through financing options (June 2024).
Key Restraints
Product recalls and safety concerns: Recent recalls have impacted market trust and sales, such as reported by Philips Respironics (June 2024).
Limited reimbursement coverage: Insufficient insurance for advanced devices restricts patient access, a challenge highlighted by Invacare Corporation in multiple 2024 stakeholder reports.
By 2025, therapeutic devices will continue to dominate the North America respiratory care devices market, accounting for the largest share due to robust use in hospitals and homecare, especially among chronic respiratory patients. Monitoring devices are gaining momentum as remote and preventive health solutions become critical to disease management, while consumables and accessories maintain steady demand given their essential role in device operations. Diagnostic device use is also on the rise, propelled by increased screening initiatives. This diverse landscape reflects the region’s multifaceted approach to respiratory healthcare and the importance of advanced, patient-centric technologies.
The Chronic Obstructive Pulmonary Disease (COPD) segment leads respiratory care device usage in North America by 2025, representing the largest share as COPD prevalence remains high among the aging population and is exacerbated by urban air pollution. Asthma ranks second, driven by heightened awareness, earlier diagnosis, and newer rescue and maintenance therapies. The significant incidence of sleep-related breathing disorders further bolsters the obstructive sleep apnea segment, while other conditions collectively show stable demand. This dynamic reflects a broad, mature market catering to acute and chronic respiratory challenges across diverse patient profiles.
The North America respiratory care devices market shows robust revenue growth, increasing from 8,700 million in 2020 to an anticipated 13,900 million by 2025 and projected to reach 25,500 million by 2035. This consistent upward trend is driven by rising disease prevalence, adoption of novel technologies, and expansion of telehealth and home-based care. Accelerated regulatory approvals and investment in innovation by leading companies are also boosting long-term sustainability and resilience in market revenue.
The market’s year-over-year growth is expected to remain strong between 2020 and 2025, reaching a peak YOY rate of 7.2% in 2022 due to heightened pandemic-era demand. Growth normalizes to around 6% by 2025 and continues at a steady 5–6% annually through 2035, reflecting ongoing innovation, heightened chronic respiratory conditions, and expanded homecare solutions. Although the pace moderates, sustained innovation and greater awareness support stable growth throughout the forecast period.
The United States dominates the North America respiratory care devices market in 2025, accounting for 78% market share, thanks to advanced healthcare infrastructure, robust reimbursement systems, and the presence of major market players. Canada represents 12% of the market due to its universal healthcare and steady adoption of new respiratory technologies. Mexico, with a 10% share, shows the fastest relative growth as respiratory care investments increase. The region’s collective efforts in public health, technology adoption, and disease management result in a balanced, progressive market.
Key players in the North American respiratory care devices market continue to maintain strong positions through differentiation and strategic partnerships. In 2025, Philips Healthcare commands 19% market share, closely followed by ResMed at 16% and Medtronic at 14%. Other significant players include Fisher & Paykel Healthcare and GE Healthcare, collectively driving innovation and competition. Market leadership is sustained by a combination of product pipeline strength, brand reputation, and the ability to navigate complex regulatory landscapes.
In 2025, hospital pharmacies are the largest buyers of respiratory care devices in North America, representing 38% of the market demand due to centralized procurement and acute care needs. Retail pharmacies account for 28%, reflecting growing patient access to home-based devices. Online pharmacies have gained substantial ground, now making up 15% of purchases as telehealth and direct-to-consumer models proliferate. These trends underscore increased accessibility, digital transformation, and the growing consumerization of medical device purchasing.
June 2024: Philips Healthcare introduced the DreamStation 3 CPAP and BiPAP systems with integrated telehealth remote monitoring.
July 2024: Medtronic launched portable AI-powered respiratory distress monitoring devices targeted for homecare settings.
June 2024: Masimo announced the rollout of a cloud-connectivity platform for hospital and home-use pulse oximeters.
August 2024: GE Healthcare entered a strategic partnership for expanding tele-respiratory solutions across underserved North American regions.
July 2024: Drägerwerk AG & Co. KGaA released its advanced electrostatic and HEPA filtration system for intensive care ventilators.
Frequently Asked Questions
About the Author
Clara
Senior Market Research Analyst
Clara is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Clara brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Clara has helped organizations translate data into actionable growth strategies.
